Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Sep 29, 2020
| Rachel Schwartz
Securing Access and Savings: By the Numbers
Report
Sep 29, 2020
| Erica Klinger
2020 Generic Drug & Biosimilars Access and Savings in the U.S. Report
Video
Sep 29, 2020
| Erica Klinger
Rich's Story — Savings from Generic Medicines
Blog
Sep 29, 2020
| Erica Klinger
2020 Report
Blog
Sep 24, 2020
| Bob Billings
Thank you, Rep. Henry Waxman
Blog
Sep 18, 2020
| Jewel Smith
Member Spotlight: Apotex
Fact Sheet
Sep 16, 2020
| Erica Klinger
How to Talk About High Drug Costs in a Time of Economic Insecurity
Video
Sep 10, 2020
| Erica Klinger
Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual Conference
Blog
Sep 9, 2020
| Dan Leonard
Generics: The Bridge to A Vaccine
Press Release
Aug 25, 2020
| Rachel Schwartz
Association for Accessible Medicines Names New President and CEO
Press Release
Aug 10, 2020
| Rachel Schwartz
Lisa Steelman Joins AAM as Vice President, State Government Affairs
Press Release
Aug 6, 2020
| Rachel Schwartz
Generic and Biosimilar Industry Statement on Essential Medicines Executive Order
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action